4Ramaehandran S, Song MQ, Lowe E, et al. RU486 inhibits ex- pression of lysophosphatidic acid induced glycodelin. Am JobstetGy- necol,2005,192(4) :1285.
5EisingerSH, Meldrum S, FiscellaK, et al. Low-dosemifepristone for uterine leiomyomata. ObstetGynecol, 2003,101 (2) :243.
6EisingerSH, BonfiglioT, FiscellaK, et al. Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas. Jminim Inva- siveGyneco1,2005,12(3 ) :227.
6[3]Rein Ms,Barbieri RL,Friedman AJ.Progesterone:a critical role in the pathogenesis of uterine myomas.Am J Obstet Gynecol,1995,172:14
7[4]Murphy AA,Kettel LM,Morales AJ,et al.Regression of uterine leiomyoma in response to antiprogestin mifepristone.J Clin Endocrinol Metab,1993,76:513
8[9]Reinsch RC,Murphy AA,Morales AJ,et al.The effects of RU486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus:a prospective,randomized study.Am J Obstet Gynecol,1994,170:1623
9[10]Stovall TG.GnRH-a utilization before hysterectomy.Clin Obstet Gynecol,1993,36:642
10Jeffrey R, Nelson Do ,stepren L. Long -lema management of adenomysis with a gonadotropin - releasing homaone agonist: a case report. Fertil steril, 1993,59:441-443.
